公司資料
Rockwell Medical 股價、新聞與催化劑
- 股票代碼:
- RMTI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
7.49 USD (+1.01%)
收盤價
最後更新: 2026年8月17日
28M USD
市值
股價為何變動
As of Aug 17, 2026, RMTI closed up 1.01% at $7.49. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Rockwell Medical is a specialty pharmaceutical and device company focused on iron management and dialysis care. Its business is centered on products used in renal treatment settings.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Rockwell sits in specialty biopharma and renal care.
商業模式特徵
The company depends on product adoption, dialysis-market access, and the economics of renal treatment workflows.
生技產業定位
Rockwell is a niche renal-care company whose stock moves on commercial execution and product use.
未來催化劑
- Rockwell Medical’s catalysts are dialysis-iron demand, manufacturing execution, and continued commercialization of Triferic and related products. Investors will watch whether recurring dialysis workflows keep supporting the story.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。